×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DMIIU – drugs made in america acquisition ii corp. - unit (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DMIIU
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
10:31 am
dmiiu
Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is largely controlled by institutional shareholders who own 79% of the company [Yahoo! Finance]
Low
Report
Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is largely controlled by institutional shareholders who own 79% of the company [Yahoo! Finance]
12/3
06:45 am
dmiiu
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025 [Yahoo! Finance]
Low
Report
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025 [Yahoo! Finance]
12/3
06:34 am
dmiiu
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025
Low
Report
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025
9/26
04:05 pm
dmiiu
Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering
Low
Report
Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering
9/25
06:43 am
dmiiu
Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public Offering
Low
Report
Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public Offering
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/18
04:06 pm
dmiiu
Form 10-Q Drugs Made In America For: Sep 30
Low
Report
Form 10-Q Drugs Made In America For: Sep 30
11/18
06:02 am
dmiiu
Form 8-K Drugs Made In America For: Oct 08
Low
Report
Form 8-K Drugs Made In America For: Oct 08
11/17
06:09 am
dmiiu
Form NT 10-Q Drugs Made In America For: Sep 30
Low
Report
Form NT 10-Q Drugs Made In America For: Sep 30
10/17
12:51 pm
dmiiu
Form 4 Drugs Made In America For: Sep 26 Filed by: Do Catherine
Low
Report
Form 4 Drugs Made In America For: Sep 26 Filed by: Do Catherine
10/2
05:15 pm
dmiiu
Form 8-K Drugs Made In America For: Sep 26
Neutral
Report
Form 8-K Drugs Made In America For: Sep 26
10/2
02:52 pm
dmiiu
Form 4 Drugs Made In America For: Sep 26 Filed by: Shulgan Myron W.
Neutral
Report
Form 4 Drugs Made In America For: Sep 26 Filed by: Shulgan Myron W.
10/2
06:07 am
dmiiu
Form SCHEDULE 13D Drugs Made In America Filed by: Drugs Made In America Acquisition II LLC
Low
Report
Form SCHEDULE 13D Drugs Made In America Filed by: Drugs Made In America Acquisition II LLC
10/1
03:49 pm
dmiiu
Form 4 Drugs Made In America For: Sep 26 Filed by: Worman Glenn C.
Low
Report
Form 4 Drugs Made In America For: Sep 26 Filed by: Worman Glenn C.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: